GlassScriptPhysician profile
Klara Kaldi Joseph
NPI 1265990618
$2,174.05
in general payments reported to CMS, 2019-2025
23 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $674 · 2022: $467 · 2023: $485 · 2024: $206 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.00 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $477.65 | 2021-2024 | |
| Astellas Pharma US INC | $274.24 | 2021-2023 | Veozah, Myrbetriq |
| Novo Nordisk INC | $262.28 | 2021-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $176.38 | 2021-2023 | |
| Pfizer INC. | $165.46 | 2022-2025 | |
| Mimedx Group, INC. | $118.56 | 2025 | |
| Sumitomo Pharma America, INC. | $103.20 | 2024-2025 | Myfembree |
| Hologic Sales and Service, LLC | $82.23 | 2021-2024 | Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Organon LLC | $81.63 | 2023-2025 | Nexplanon |
| Daiichi Sankyo INC. | $81.53 | 2021-2022 | |
| Biogen, INC. | $46.23 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $43.82 | 2021-2024 | Slynd |
| Therapeuticsmd, INC. | $36.50 | 2022 | |
| Millicent US INC | $34.06 | 2024-2025 | Femring, Intrarosa |
| Agile Therapeutics, INC. | $29.07 | 2021-2023 | Twirla |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $25.23 | 2024-2025 | |
| Evofem Biosciences, INC. | $24.53 | 2023 | Phexxi |
| Axonics, INC. | $22.73 | 2023 | Axonics |
| Myovant Sciences INC. | $21.59 | 2021 | |
| Mylan Pharmaceuticals INC. | $19.54 | 2021 | |
| Medtronic, INC. | $16.21 | 2022 | |
| Virtus Pharmaceuticals LLC | $15.93 | 2021 | |
| Amgen INC. | $15.45 | 2025 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Klara Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.